Trial intelligence / Profile preview

NILE: Nitazoxanide and Lansoprazole Regimens for H. Pylori

NCT05184491Phase 4Unknown

Sponsor
National Liver Institute
Start
Oct 2021
Primary completion
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nitazoxanide in Helicobacter pylori infection, sponsored by National Liver Institute. Status: unknown.

02

Drugs

nitazoxanide
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT05184491.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05184491.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call